Does ECULIZUMAB Cause Haemolysis? 1,476 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,476 reports of Haemolysis have been filed in association with ECULIZUMAB (SOLIRIS). This represents 3.3% of all adverse event reports for ECULIZUMAB.
1,476
Reports of Haemolysis with ECULIZUMAB
3.3%
of all ECULIZUMAB reports
87
Deaths
557
Hospitalizations
How Dangerous Is Haemolysis From ECULIZUMAB?
Of the 1,476 reports, 87 (5.9%) resulted in death, 557 (37.7%) required hospitalization, and 63 (4.3%) were considered life-threatening.
Is Haemolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ECULIZUMAB. However, 1,476 reports have been filed with the FAERS database.
What Other Side Effects Does ECULIZUMAB Cause?
Fatigue (4,858)
Off label use (4,228)
Haemoglobin decreased (3,028)
Headache (2,699)
Death (2,221)
Pyrexia (1,948)
Dyspnoea (1,819)
Asthenia (1,732)
Drug ineffective (1,644)
Nausea (1,579)
What Other Drugs Cause Haemolysis?
HUMAN IMMUNOGLOBULIN G (357)
RITUXIMAB (261)
RAVULIZUMAB-CWVZ (242)
PREDNISONE (192)
CYCLOSPORINE (173)
DEXAMETHASONE (167)
ACETAMINOPHEN (134)
VINCRISTINE (132)
TACROLIMUS (116)
CYCLOPHOSPHAMIDE (110)
Which ECULIZUMAB Alternatives Have Lower Haemolysis Risk?
ECULIZUMAB vs EDARAVONE
ECULIZUMAB vs EDETATE
ECULIZUMAB vs EDOXABAN
ECULIZUMAB vs EDOXABAN TOSILATE
ECULIZUMAB vs EFALIZUMAB